Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
Abstract The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is characterized by the emission of damage-associated molecular patterns (DAMPs) from dying cells. This emission can trigger eff...
Guardado en:
Autores principales: | Victoria D. Turubanova, Tatiana A. Mishchenko, Irina V. Balalaeva, Iuliia Efimova, Nina N. Peskova, Larisa G. Klapshina, Svetlana A. Lermontova, Claus Bachert, Olga Krysko, Maria V. Vedunova, Dmitri V. Krysko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41e549963f9b4302b7339409a3df2132 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
por: Razan Alzeibak, et al.
Publicado: (2021) -
Macrophages regulate the clearance of living cells by calreticulin
por: Dmitri V. Krysko, et al.
Publicado: (2018) -
Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
por: Wei Li, et al.
Publicado: (2019) -
Correction: Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
Publicado: (2021) -
Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death
por: Jin F, et al.
Publicado: (2021)